All News #Library
Biotech
Abbisko NDA for Pimicotinib in TGCT Accepted by FDA
12 Jan 2026 //
PR NEWSWIRE
Pimicotinib Provides Long-Term Tumor Responses In TGCT Patients
23 Oct 2025 //
INDPHARMAPOST
Pimicotinib Shows Durable TGCT Response, Pain Improvement
17 Oct 2025 //
BUSINESSWIRE
Pimicotinib shows high efficacy in tenosynovial Giant Cell Tumor
29 May 2025 //
INDPHARMAPOST
Abbisko to Present Ph 2 Study Results of Hepatocellular Carcinoma
12 May 2025 //
PR NEWSWIRE
Abbisko`s Pre-clinical Results on ABSK112 , ABSK131, ABK-KRAS-1
27 Apr 2025 //
PR NEWSWIRE

Market Place
Sourcing Support